MR imaging in patients with Crohn disease: value of T2- versus T1-weighted gadolinium-enhanced MR sequences with use of an oral superparamagnetic contrast agent. - Test2 - elhamkhani - TriplyDB

MR imaging in patients with Crohn disease: value of T2- versus T1-weighted gadolinium-enhanced MR sequences with use of an oral superparamagnetic contrast agent.

MR imaging in patients with Crohn disease: value of T2- versus T1-weighted gadolinium-enhanced MR sequences with use of an oral superparamagnetic contrast agent.

http://www.wikidata.org/entity/Q36350023

about

Magnetic Resonance Imaging of the Small Bowel in Crohn's Disease: A Systematic Review and Meta-Analysis The Role of MR Enterography in Assessing Crohn's Disease Activity and Treatment Response Inflammatory bowel disease imaging: Current practice and future directions Surgery and diagnostic imaging in abdominal Crohn's disease.Incidental findings at MRI-enterography in patients with suspected or known Crohn's disease.The first joint ESGAR/ ESPR consensus statement on the technical performance of cross-sectional small bowel and colonic imaging.Ultrasonographic detection and assessment of the severity of Crohn's disease recurrence after ileal resection.Magnetic resonance colonography in severe attacks of ulcerative colitis.Magnetic resonance enterography in Crohn's disease: Standard and advanced techniques.Utility of the diffusion-weighted imaging for activity evaluation in Crohn's disease patients underwent magnetic resonance enterography.Malignant tumours of the small intestine: a review of histopathology, multidetector CT and MRI aspects.Detection of inflammatory bowel disease: diagnostic performance of cross-sectional imaging modalities Crohn's disease complicated by strictures: a systematic review.Updating magnetic resonance imaging of small bowel: imaging protocols and clinical indications.Magnetic nanoparticles for multi-imaging and drug delivery.Magnetic resonance enterography in Crohn's disease: How we do it and common imaging findings.Advances in the diagnosis and management of inflammatory bowel disease: challenges and uncertainties.Contrast-enhanced MRI of the small bowel in Crohn's disease.Inflammatory activity in Crohn's disease: CE-US.Systematic review: the use of ultrasonography, computed tomography and magnetic resonance imaging for the diagnosis, assessment of activity and abdominal complications of Crohn's disease.MRI of Crohn's disease: from imaging to pathology.Results of the 2nd part Scientific Workshop of the ECCO. II: Measures and markers of prediction to achieve, detect, and monitor intestinal healing in inflammatory bowel disease.MRI in Crohn's disease--current and future clinical applications.Assessment of wall inflammation and fibrosis in Crohn's disease: value of T1-weighted gadolinium-enhanced MR imaging.Value of T2-weighted magnetic resonance imaging in the assessment of wall inflammation and fibrosis in Crohn's disease.Magnetic resonance enterography in Crohn's disease: a guide to common imaging manifestations for the IBD physician.Evolving role of MRI in Crohn's disease.Inflammatory bowel disease and novel endoscopic technologies.An overview of magnetic resonance enterography for Crohn's disease.Imaging techniques in IBD and their role in follow-up and surveillance.Multidisciplinary management of gastrointestinal fibrotic stenosis in Crohn's disease.Systematic review with meta-analysis: magnetic resonance enterography signs for the detection of inflammation and intestinal damage in Crohn's disease.MR enterography in Crohn's disease: current consensus on optimal imaging technique and future advances from the SAR Crohn's disease-focused panel.Role of Magnetic Resonance Enterography in Differentiating between Fibrotic and Active Inflammatory Small Bowel Stenosis in Patients with Crohn's Disease.Use of Imaging Techniques in Inflammatory Bowel Diseases That Minimize Radiation Exposure.Monitoring of small bowel Crohn's disease.Endoluminal contrast for abdomen and pelvis magnetic resonance imaging.Features and perspectives of MR enterography for pediatric Crohn disease assessment.Assessment of Disease Activity in Small Bowel Crohn's Disease: Comparison between Endoscopy and Magnetic Resonance Enterography Using MRIA and Modified MRIA Score.MR colonography without bowel purgation for the assessment of inflammatory bowel diseases: diagnostic accuracy and patient acceptance.

P2860

Q26742099-539A49A0-BC02-4C6D-B8E4-46EF67633F8B Q26773129-16CA8C76-0C42-4CBB-A1DC-09D69E0E2A76 Q26774602-CAFA71DC-4FC8-46B3-8181-7116BBD2F8B2 Q27000186-52FC5EEB-D21C-478D-B362-C79978E67A4C Q33565007-2E858545-787C-4517-9491-E665C83EB096 Q33611524-276C21F0-5DA2-4B9D-8DE4-701A5CA5DB21 Q33622831-B096FF30-B059-404A-87DB-B4C65CEE3CB8 Q34248930-9552079F-D3D7-4046-A1F6-9758F106BA40 Q34391707-847C01F2-F2FA-4D59-981D-826CA94BDC68 Q35068215-C05CF7FC-0B29-43A2-828F-D0D5928A8D7A Q36323900-A03048F0-4F15-46F7-96D2-E11C78BB84D4 Q36661694-DB6BF627-B458-48CD-9658-EFB71F6CE491 Q36945422-5EEECAB2-1C39-49F7-89E3-B0CF46C13DC0 Q37182973-187D25B8-2303-4B50-9EEC-0ADDCD92B3FF Q37462267-0FC1FDA4-57C7-426F-B3B4-A736675DA34E Q37678128-18A98E6D-DD8A-4B0D-8E3E-B29C7385D02F Q37703514-264DA81A-85C2-40A3-A4AC-00FF56BC8496 Q37748536-B045CC12-C28D-46F1-957C-1139F15C2697 Q37750529-1BAA8DC9-1FC2-4114-B6C3-94A118E40850 Q37880179-3CC7EDF5-030B-4C27-AFE0-DB9A42930B1E Q37924164-4DE68AFE-D089-4BAC-B211-2403C3ADC32F Q37937183-6485BBCF-6AA4-4DEA-996B-776EC5D39CC3 Q37959242-ED09C237-D123-4EC0-ABCD-5B2527F39387 Q37960387-7EFFC8F0-CBFB-4FE2-BFBA-3DE231AACA90 Q38013731-C9064B49-2BCB-480D-8F30-0FB6A41F2057 Q38057513-5518139C-6B85-4E6B-9C5A-D97D78BEAC31 Q38109870-3C08EB84-3AD1-4AAD-A389-F6CCA1D2A3DE Q38137227-0D6D498E-BB00-4104-82C8-E1744A7732D7 Q38198565-122D7DE0-576C-4210-89F3-D26B24FB606F Q38243355-108F232B-4DCA-4A24-A743-4E687A4C77C6 Q38266205-FE32FFF4-2DD6-4361-BEEE-055B188764CD Q38268900-81551C86-5D41-45B1-A9CF-42AA29434065 Q38350117-41F41912-166D-43EB-A399-3A360AFDF54B Q38537645-B21AF0FB-A97A-4CCF-9A01-02246A9DF292 Q38539966-8F4DF75C-E5DD-497F-AFF6-F0257BC10537 Q38652740-C2A72D6B-04B1-4303-9712-B5DF3A6259A1 Q38747317-BFFF1506-BD20-4543-B885-8DD830D7DDE2 Q38912879-8A94DA96-BA6D-4A7C-81B8-8D714AF8276D Q40115430-46D9178C-14DC-467B-B7EC-B694F9609698 Q40235011-47D89593-EF04-46B6-BD2A-EDD97A4AEDC1

P2860

MR imaging in patients with Crohn disease: value of T2- versus T1-weighted gadolinium-enhanced MR sequences with use of an oral superparamagnetic contrast agent.

http://www.wikidata.org/entity/Q36350023

description

2005 nî lūn-bûn

@nan

2005年の論文

@ja

2005年学术文章

@wuu

2005年学术文章

@zh-cn

2005年学术文章

@zh-hans

2005年学术文章

@zh-my

2005年学术文章

@zh-sg

2005年學術文章

@yue

2005年學術文章

@zh

2005年學術文章

@zh-hant

name

MR imaging in patients with Cr ...... erparamagnetic contrast agent.

@ast

MR imaging in patients with Cr ...... erparamagnetic contrast agent.

@en

type

label

MR imaging in patients with Cr ...... erparamagnetic contrast agent.

@ast

MR imaging in patients with Cr ...... erparamagnetic contrast agent.

@en

prefLabel

MR imaging in patients with Cr ...... erparamagnetic contrast agent.

@ast

MR imaging in patients with Cr ...... erparamagnetic contrast agent.

@en

P1433

Q36350023-79C1B066-C9AD-4018-9452-A6E4D874ECAC

P1476

Q36350023-DADF5E6D-B1B5-4C92-A344-37CDA63ACF10

P2093

Q36350023-2A8067A8-F573-4EC7-A429-A6DA321A3C0F

Q36350023-6722BE51-B05E-42F3-8AC5-156D27393C85

Q36350023-810846BB-E9D0-4233-BBD0-BA1185FD6517

Q36350023-82FA5E4B-190F-4666-A3D8-464B0D8645C9

Q36350023-8BC8F9B8-F085-4FE2-93CB-A6F0C1053BD1

Q36350023-C87DCFF9-42C7-4DF1-87FB-D3B2F328838B

P304

Q36350023-F46A40E3-B139-4AA7-A7BD-DAC6DBD4F61A

P31

Q36350023-1E3B29C0-E137-4B97-84BD-9C9AEA922701

P356

Q36350023-65FAB66D-50D2-4047-9F84-C61105158864

P407

Q36350023-7AD715BE-E415-4E29-A669-FD22F3E043C0

P433

Q36350023-EE8A4CA8-E719-4116-B5A8-CDFC8C5BA4A4

P478

Q36350023-07282F2B-1F7F-4B96-BD9D-FFB8ADCFA14D

P50

Q36350023-03DAE8CD-9E5A-4D96-A68D-BA17B395231D

Q36350023-BD5FEC18-8F78-4DF4-944A-3E03EFD20B38

P577

Q36350023-941FEED0-6CC2-45F2-8053-2F706AFBFE3B

P698

Q36350023-B0DF0EA2-718B-40F2-8E2C-86C2ADB5507F

P356

RADIOL.2381040244

P1433

P1476

MR imaging in patients with Cr ...... erparamagnetic contrast agent.

@en

P2093

Andrea Cocco

http://www.w3.org/2001/XMLSchema#string

Antonio Bruni

http://www.w3.org/2001/XMLSchema#string

Chiara Montesani

http://www.w3.org/2001/XMLSchema#string

Maria Chiara Colaiacomo

http://www.w3.org/2001/XMLSchema#string

Mario Marini

http://www.w3.org/2001/XMLSchema#string

Renzo Caprilli

http://www.w3.org/2001/XMLSchema#string

P304

517-530

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1148/RADIOL.2381040244

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

238

http://www.w3.org/2001/XMLSchema#string

P50

Francesca Maccioni

P577

2005-12-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

16371574

http://www.w3.org/2001/XMLSchema#string